# Juvaris BioTherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/juvaris-biotherapeutics

- Industry: Pharmaceuticals
- Headquarters: Burlingame, US
- Website: www.juvaris.com
- Total disclosed funding: $66M
- Latest round: Series B (Apr 12, 2010)
- Investors on record: 2

## About

Juvaris BioTherapeutics, Inc. is developing novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The Company is also developing vaccines for HSV-2, universal flu and pandemic flu.

## Funding rounds

- Series B, Apr 12, 2010, $13M — Kleiner Perkins, SV Health Investors
- Series B, Jan 27, 2010, $25M — Kleiner Perkins, SV Health Investors
- Series B, Sep 11, 2009, $15M — Kleiner Perkins, SV Health Investors
- Series A, Oct 24, 2007, $6M — Kleiner Perkins
- Series A, Feb 16, 2007, $2.3M — Kleiner Perkins
- Series A, Dec 8, 2006, $5.5M — Kleiner Perkins

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series B